An infant formula toxicity and toxicokinetic feeding study on carrageenan in preweaning piglets with special attention to the immune system and gastrointestinal tract

Food and Chemical Toxicology

Volumn 77, Issue , 2015, Pages 120-131

  Weiner, M L ^a   Ferguson, H E ^b   Thorsrud, B A ^c   Nelson, K G ^c   Blakemore, W R ^d   Zeigler, B ^c   Cameron, M J ^c   Brant, A ^c   Cochrane, L ^c   Pellerin, M ^c   Mahadevan, B ^b  

^a TOXpertise LLC   (United States)

^b ABBOTT LABORATORIES   (United States)

^c MPI RESEARCH   (United States)

^d Celtic Colloids Inc   (United States)

Author keywords

Carrageenan; Gastrointestinal tract; Immune system; Infant formula; Piglet

Indexed keywords

CARRAGEENAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL MILK; B LYMPHOCYTE; BLOOD LEVEL; BODY GROWTH; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FECES ANALYSIS; FEMALE; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; GLUCOSURIA; HELPER CELL; IMMUNE SYSTEM; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LIMIT OF QUANTITATION; MALE; MONOCYTE; NONHUMAN; ORGAN WEIGHT; PIGLET; SANDWICH IMMUNOASSAY; TOXICOKINETICS; URINALYSIS; WEIGHT GAIN; YORKSHIRE PIG; ANIMAL; BLOOD; BODY WEIGHT; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; NEWBORN; ORGAN SIZE; PIG; TOXICITY TESTING;

ANIMALIA; PAPIO; SUIDAE;

ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CARRAGEENAN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL TRACT; IMMUNE SYSTEM; INFANT FORMULA; INTERLEUKIN-1BETA; INTERLEUKIN-6; INTERLEUKIN-8; MALE; ORGAN SIZE; SWINE; TOXICITY TESTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84922211487     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.12.022     Document Type: Article

References (40)

1. Abraham R., et al. Chronic and subchronic effects of various forms of carrageenan in rats. Ecotoxicol. Environ. Saf 1985, 10:173-183.
2. Andrikopoulos S., et al. Evaluating the glucose tolerance test in mice. Am. J. Physiol. Endocrinol. Metab 2008, 295(6):E1323-E1332.
3. Barrow P.C. Use of the swine pediatric model. Pediatric Non-Clinical Drug Testing: Principles, Requirements, and Practice 2012, 213-230. John Wiley & Sons, Inc., Hoboken, NJ. A.M. Hoberman, E.M. Lewis (Eds.).
4. Bhattacharyya S., et al. Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signaling in HepG2 cells and C57BL/6J mice. Diabetologia 2012, 55(1):194-203.
5. Blakemore W.R., et al. Carrageenan analysis. Part 1: characterisation of the carrageenan test material and stability in swine-adapted infant formula. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess 2014, 31(10):1661-1669. 10.1080/19440049.2014.955536.
6. Blakemore W.R., et al. Carrageenan analysis. Part 2: quantification in swine-adapted infant formula. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess 2014, 31(10):1670-1672. 10.1080/19440049.2014.955537.
7. Blakemore W.R., et al. Carrageenan analysis. Part 3: quantification in swine plasma. Food Addit. Contam. Part A Chem. Anal. Control Expo. Risk Assess 2014, 31(10):1673-1677. 10.1080/19440049.2014.955538.
8. Buelke-Sam, J., 2002. Postnatal Evaluation in Developmental and Juvenile Toxicity Studies, presented at the Henry Stewart Conference; Meeting FDA, EPA, OECD and ICH Regulatory Requirements for Reproductive Toxicology Data Submissions. Georgetown University Conference Center, Washington, DC.
9. Canada Gazette, 2004. 138, No. 20: May 15, Item A.5.
10. Codex Committee on Food Additives, 2008. Report of the 40th session (2008) of the CCFA to the 31st session (2008) of the Codex Alimentarius Commission. ALINORM 08/31/12, May.
11. Davidson T.L., Swithers S.E. Food viscosity influences caloric intake compensation and body weight in rats. Obes. Res 2005, 13:537-544.
12. Dilger R.N., Johnson R.W. Behavioral assessment of cognitive function using a translational neonatal piglet model. Brain Behav. Immun 2010, 24:1156-1165.
13. Dunnett C.W. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc 1955, 50:1096-1121.
14. European Medicines Agency (EMEA), 2008. Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications. EMEA Guideline, 24 Jan 2008.
15. Farmer C., Questnel H. Nutritional, hormonal and environmental effects of colostrums in sows. J. Anim. Sci 2009, 87(Suppl. 1):56-65.
16. Guilloteau P., et al. Nutritional programming of gastrointestinal tract development. Is the pig a good model for man?. Nutr. Res. Rev 2010, 23:4-22.
17. Hall R.L. Principles of clinical pathology. Principles of Clinical Pathology in Toxicologic Pathology: Nonclinical Safety Assessment 2013, 133-174. CRC Press, Boca Raton, FL. P.S. Sahota, J.A. Popp, J.F. Hardisty, C. Gopinath (Eds.).
18. Helm R.M., et al. Diet regulates the development of gut-associated lymphoid tissue in neonatal piglets. Neonatology 2007, 91:248-255.
19. International Conference on Harmonisation (ICH) Harmonised Tripartite Guidelines, 2010. Guidance for industry on non-clinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals. ICH M3(R2), 2010 Jan.
20. International Programme on Chemical Safety (IPCS), 2009. Environmental Health Criteria 240, Principals and methods for the risk assessment of chemicals in food. <>. http://www.inchem.org/documents/ehc/ehc/ehc240_index.html.
21. JECFA: Joint FAO/WHO Expert Committee on Food Additives, 2008. 68th Report of the Joint FAO/WHO Expert Committee on Food Additives; Evaluation of Certain Food Additives and Contaminants. WHO Technical Report Series 947, 32-37.
22. JECFA: Joint FAO/WHO Expert Committee on Food Additives 79th Meeting, Geneva, 17-26 June 2014, Summary and Conclusions, JECFA79/SC http://www.fao.org/fileadmin/templates/agns/pdf/jecfa/JECFA_79_Summary_Version_Final.pdf.
23. Klobasa F., et al. Composition of sow's milk during lactation. J. Anim. Sci 1987, 64:1458-1466.
24. McGill H.C., et al. Carrageenan in formula and infant baboon development. Gastroenterology 1977, 73:512-517.
25. McKim J.M. Food additive carrageenan: part I: a critical review of carrageenan in vitro studies, the potential pitfalls, and implications for human health and safety. Crit. Rev. Toxicol 2014, 44(3):211-243.
26. Milliken G.A., Johnson D.E. Analysis of Messy Data 1992, Chapman and Hall, London.
27. National Research Council Infant Formula: Evaluating the Safety of New Ingredients 2004, National Academies Press, Washington, DC.
28. Odel J., et al. The suckling piglet as an agrimedical model for the study of pediatric nutrition and metabolism. Annu. Rev. Anim. Biosci 2014, 2:419-444.
29. Parfitt J.R., Driman D.K. Pathological effects of drugs on the gastrointestinal tract: a review. Hum. Path 2006, 38:527-536.
30. Penninks A.H., et al. Juvenile immunodevelopment in minipigs. Pediatric Non-Clinical Drug Testing: Principles, Requirements, and Practice 2012, 231-254. John Wiley & Sons, Inc., Hoboken, NJ. A.M. Hoberman, E.M. Lewis (Eds.).
31. Rothkotter H.J., et al. The pig as a model for developmental immunotoxicology. Developmental Immunotoxicology 2005, 103-114. CRC Press, Boca Raton, FL. S.D. Holladay (Ed.).
32. Snedecor G.W., Cochran W.C. Statistical Methods 1982, Iowa State University Press, Ames, IA. seventh ed.
33. Thorsrud B., et al. The development and validation of methods for evaluating the immune system in pre-weaning piglets. Toxicol. Sci 2014, 138(1):845. Abstract.
34. United Stated Food and Drug Administration (FDA) Guidance for Industry: E11 Clinical Investigation of Medicinal Products in the Pediatric Population http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073143.pdf.
35. United States Food and Drug Administration (FDA) Center for Drug Evaluation and Research (CDER) Guidance on Nonclinical Safety Evaluation of Pediatric Drug Products Nonclinical Safety Evaluation of Pediatric Drug Products 2006, U.S. Department of Health and Human Service, Rockville, MD.
36. Uno Y., et al. Molecular weight and fecal excreted quantity of carrageenan administered to rats in blended feed. Jpn. J. Food Chem 2001, 8:83-93.
37. Weiner M.L. Food additive CGN: part II: a critical review of carrageenan in vivo safety studies. Crit. Rev. Toxicol 2014, 44(3):244-269.
38. Weiner M.L., et al. A 90-day dietary study of kappa carrageenan with emphasis on the gastrointestinal tract. Food Chem. Toxicol 2007, 45:98-106.
39. Welch B.L. The significance of difference between two means when the population variances are unequal. Biometrika 1937, 29:350-362.
40. Xu R.J. Composition of Porcine Milk in the Neonatal Pig: Gastrointestinal Physiology and Nutrition 2003, 213-246. Nottingham University Press, Nottingham, UK. R.J. Xu, P. Cranwell (Eds.).